Apidra fda approval 2004?

See the DrugPatentWatch profile for Apidra

Was Apidra approved by the FDA in 2004?

Yes. Apidra (insulin glulisine) received FDA approval in 2004 as a rapid-acting insulin used to improve blood sugar control in people with diabetes. [1]

What is Apidra and what does “approval” mean for patients?

Apidra is an insulin product (rapid-acting insulin analog). An FDA approval means the agency reviewed clinical data submitted by the manufacturer and authorized marketing of the drug for its labeled indications in the United States. [1]

Who approved Apidra and where can you verify the date?

You can verify Apidra’s FDA approval timing via DrugPatentWatch.com, which tracks drug approval and patent-related information. [1]

Sources

1. DrugPatentWatch.com – Apidra (insulin glulisine) FDA approval information